Literature DB >> 28948916

Vaccine against Zika virus must remain a priority.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28948916     DOI： 10.1016/S1473-3099(17)30534-0

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  2 in total

1.  Zika virus envelope nanoparticle antibodies protect mice without risk of disease enhancement.

Authors:  Rahul Shukla; Rajgokul K Shanmugam; Viswanathan Ramasamy; Upasana Arora; Gaurav Batra; Joshua A Acklin; Florian Krammer; Jean K Lim; Sathyamangalam Swaminathan; Navin Khanna
Journal:  EBioMedicine       Date:  2020-04       Impact factor: 8.143

2.  An attenuated Zika virus NS4B protein mutant is a potent inducer of antiviral immune responses.

Authors:  Guangyu Li; Awadalkareem Adam; Huanle Luo; Chao Shan; Zengguo Cao; Camila R Fontes-Garfias; Vanessa V Sarathy; Cody Teleki; Evandro R Winkelmann; Yuejin Liang; Jiaren Sun; Nigel Bourne; Alan D T Barrett; Pei-Yong Shi; Tian Wang
Journal:  NPJ Vaccines       Date:  2019-11-28       Impact factor: 7.344
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.